AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,465,000 | -74.0% | 500,000 | +25.0% | 0.31% | -72.7% |
Q1 2018 | $5,632,000 | +19.7% | 400,000 | 0.0% | 1.14% | +3.3% |
Q4 2017 | $4,704,000 | -17.1% | 400,000 | 0.0% | 1.10% | -8.5% |
Q3 2017 | $5,676,000 | +34.5% | 400,000 | +33.3% | 1.20% | +37.4% |
Q2 2017 | $4,221,000 | +12.4% | 300,000 | +33.3% | 0.88% | +25.3% |
Q1 2017 | $3,755,000 | +1.1% | 225,000 | 0.0% | 0.70% | -21.7% |
Q4 2016 | $3,715,000 | +11.2% | 225,000 | -10.0% | 0.89% | +64.9% |
Q3 2016 | $3,340,000 | – | 250,000 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |